BioSpace News Archive

Marinus Pharmaceuticals Announces U.S. Commercial Launch of ZTALMY ® (ganaxolone) for Seizures Associated With CDKL5 Deficiency Disorder.

Organon and Cirqle Biomedical today announced they have entered into a research collaboration and exclusive license agreement for a novel investigational non-hormonal, on-demand contraceptive candidate.

Xtant Medical Holdings, Inc. today announced that it will release its financial results for the second quarter ended June 30, 2022, before the open of the financial markets on Thursday, August 4, 2022.

Achieve Life Sciences, Inc. today announced it will report its second quarter financial results and provide an update on the cytisinicline development program on Thursday, August 11, 2022, at 4:30 PM EDT.

Ardelyx, Inc. today announced that it will hold a conference call on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time to review second quarter 2022 financial results and provide a business overview.

InnerScope Hearing Technologies Inc. (OTC: INND) (“InnerScope”), an emerging and disruptive leader in the Direct-to-Consumer Hearing Technology space, is pleased to announce today that its wholly-owned subsidiary HearingAssist has received $2,750,000 for its Receivable Factoring Agreement (“Factoring Agreement”) with Star Funding Inc. (“Star Funding”).

Arcadia Biosciences, Inc. today announced that it will release its financial and business results for the second quarter and first half of 2022 after market close on August 11, 2022.

TetraScience, the Scientific Data Cloud company, announced today that ACD/Labs, a leading provider of scientific software for R&D, has joined the Tetra Partner Network to help pharma and biopharma customers achieve greater scientific insights and outcomes.

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report second quarter financial results on Thursday, August 4, 2022.

Ozette Technologies, Inc., a technology-driven life sciences startup engineering a transformative leap in cell discovery and annotation of the human immune system, today announced its $26MM Series A funding, led by Madrona Ventures.